跳至主要内容
临床试验/IRCT20170902036032N1
IRCT20170902036032N1招募中4 期

Compare the effect of ondansetron and Dexamethasone with metoclopramide and Dexamethasone in the control of nausea and vomiting after chemotherapy in cancer patients referred to Imam Hossein hospitals of Shahroud on 2017, a randomized double blind clinical trial

Shahroud University of Medical Sciences0 个研究点目标入组 86 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 65 years(—)
性别
All

入选标准

  • A definitive diagnosis of a cancer that needs chemotherapy
  • There is no other systemic disease (such as obstructive bowel disease and gastroenteritis, central nervous system problems, and equilibrium problems)
  • Have a previous history of chemotherapy at least three times
  • Age range 15 to 65 years
  • Fear and complain about severe and fairly intense nausea and vomiting in previous chemotherapy
  • No use oral antinausea or injection medicines in the last 7 days
  • Desire and satisfaction to enter the study

排除标准

  • Use an anti-nausea and vomiting medicine for at least the past 7 days
  • Dissatisfaction with this treatment
  • Those who use drugs
  • There is a severe allergic reaction to either of the two drugs, Endonestrone and Metoclopramide
  • Dissatisfaction with cooperation and participation in the project

研究者

相似试验